Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Plus components not separately reported this period.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s EBIT?
- Vir Biotechnology, Inc. (VIR) reported EBIT of $73.47M in Q2 2026.
- How has Vir Biotechnology, Inc.'s EBIT changed year-over-year?
- Vir Biotechnology, Inc.'s EBIT increased by 162.0% year-over-year, from -$118.42M to $73.47M.
- What is the long-term trend for Vir Biotechnology, Inc.'s EBIT?
- Over 3 years (2021 to 2025), Vir Biotechnology, Inc.'s EBIT has grown at a 4.4% compound annual growth rate (CAGR), from $420.75M to -$479.33M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Vir Biotechnology, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude